Works at the interface of molecular medicine and oncology, using 3D cell and animal models, CRISPR, and immunoassays to study DNA repair, adhesion and immune pathways, enabling preclinical drug evaluation and immunotherapy testing. Also develops quantitative genomic prediction models.